# Morningstar share price today (Morningstar, Inc., MORN)

> Morningstar, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. MORN · Financials · Financial Data & Stock Exchanges · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/morn

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from the last 12 quarters
- Price: $236.71 (+11.5% in a year)
- P/BV: 8.6× (higher than 66% of the last 5.3 years)
- Revenue (Jun 2026): $663 M (+9.6% on a year ago)
- Profit (Jun 2026): $108 M (+21.1% on a year ago)
- Net margin: 16.3% (+1.6 points on a year ago)
- ROE: 35%, FY25
- ROA: 10.27%, latest

Biggest thing to watch: the P/BV is higher than 66% of its own history, so the multiple has already done part of the work. ## What is the Morningstar share price today? Morningstar, Inc.'s share price was $236.71 at the close on 3 November 2026. It has been stalling near its high for 5 weeks. That is 27.3% above its average price over the last 200 trading days. In the last 52 weeks it traded between $154 and $237, and at that close it was at the high of that range. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 15 weeks in a row. Over the last 10 years the share price moved +191% while the S&P 500 moved +255%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Morningstar pay? Morningstar, Inc. paid $1.96 per share over the last four reported quarters. The most recent declaration was $0.50 for Jun 2026. At today's price of $236.71 that is a yield of 0.83%, based on dividends already paid, not a forecast. ## Which stock lists is Morningstar on? Morningstar is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Morningstar profitable? Morningstar, Inc. earned $108 M of net profit in the Jun 2026 quarter, +21.1% on the same quarter a year earlier. That is the 2nd quarter in a row of profit growth. Full-year FY25 profit was $374 M. Over 4 years profit has grown 18.0% a year on average. That is 16.3% of the quarter's revenue. The same quarter a year earlier earned $89.0 M. For the full year, FY25 profit was $374 M (+1.2% on the year before). Why profit moved: revenue changed +9.6% on a year earlier and the margin moved +1.6 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +8.1% and revenue +9.3%. Profit and revenue are moving at about the same pace. ## How much revenue does Morningstar make, and is it growing? Morningstar, Inc. reported $663 M of income in the Jun 2026 quarter, +9.6% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 4 years it has grown 9.5% a year on average. The last full year, FY25, came in at $2.4 B. The last four reported quarters add to $2.6 B. FY25 revenue was $2.4 B, +7.5% on the year before. Recent pace: the last four quarters grew +9.3% on average, against 9.5% a year over the longer run, so this year is growing at about the same pace as its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +9.3%, against +8.8% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +4.3%, against +30.9% a year (rolling over). ## How much does Morningstar keep from what it earns? Morningstar, Inc.'s net margin was 16.3% in the Jun 2026 quarter, 1.6 percentage points higher than the same quarter a year ago. Across 5 years it has been between 3.8% and 16.3%. The latest quarter is within that range. Why: the net margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason. ## How many of Morningstar's loans have gone bad? Morningstar, Inc. does not report loan-quality figures this page can read, so this section says so rather than guess. No bad-loan figures are filed in a form this page can read, and none are guessed from the profit line. The income, margin and return sections carry what this business does report. Why: loan quality drives a lender, but its details (new bad loans, recoveries, money set aside) are not in our data for this company. The sections around this one carry what we can back up. ## How fast is Morningstar's loan book growing? Morningstar, Inc.'s revenue was $2.4 B in FY25, +7.5% on the year before, so the loan book is growing. The latest quarter was +9.6% on a year earlier. The net margin on that income is 16.3%, +1.6 percentage points on a year ago. Interest income stands in for the size of the loan book; changes in interest rates can move it a few points in any year. In short: a lender grows well when its loan book grows, its margin stays steady and its loans stay clean. Quarterly loan-quality figures are missing here, so revenue growth and margin are the two we watch. ## What is Morningstar's P/BV ratio, and how does it compare with its own history? Morningstar, Inc.'s P/BV is 8.6×, in the middle of its own history: higher than 66% of past readings. Its usual P/BV (the middle reading) is 8.2×, over 5.3 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year book value grew while the price moved +11.5%. The price ran ahead of book value, which pushed the multiple up within its own range. Where the price move came from: over 5 years the price moved −5.4% a year; about −3.2% a year came from book-value growth and about −2.2 percentage points from the multiple (the market paying less). The split is approximate (price return minus book-value growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the book value trend underneath matters more than the multiple. ## Is the Morningstar business getting better or worse? Morningstar, Inc.'s business is giving mixed signals. There is no clear direction across the growth lines, with ROE rising at 41.2%; each line tells part of the story. This is based on 12 quarters of 4 measures. Why it matters: when the lines disagree, each line above matters more than any single label. ## How much does Morningstar earn on its equity and assets? Morningstar, Inc. earned a return on equity of 31% in FY25. Its lowest yearly reading on file was 6% in FY22. On its assets, every $100 earned about $10.27, before the effect of borrowing. For a lender the balance sheet is the business, so the return on equity and on assets have to be read together. That is above the level a bank needs to grow its net worth steadily. Why ROE moved: profit grew 18.0% a year over 4 years while net worth grew more slowly. When earnings recover faster than net worth builds up, ROE climbs off its low. ## Does Morningstar have too much debt? For a bank, borrowing is the raw material of the business, not a warning sign: it borrows money in order to lend it out. Its safety is read through its returns and its loans. Its safety is read from the bad-loan figures and the return on equity instead. For a manufacturer, debt is a claim on its profits. For a lender it is the stock it trades in, so the usual debt-to-equity test would mislead and is not used here. ## What is the Morningstar shareholding pattern? 6.5% of Morningstar, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 4.3 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Morningstar from balance-sheet trouble? For Morningstar, Inc., the Z-score is not used, because it was built for manufacturers, not lenders. For a lender, safety is read from its capital and bad-loan figures instead. ## How does Morningstar rank in its industry? 68.2 out of 100, rank 2 of 14 in Financial Data & Stock Exchanges, with 76% of the evidence available. Morningstar, Inc. scores 68.2 out of 100 against the 14 companies it is compared with in Financial Data & Stock Exchanges, ranking 2. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 19.5 + 17.9 + 11.5 + 19.3 = 68.2. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if ROA turns down or gross NPA rises while the share price lags its sector. ## Which companies is Morningstar compared with? Morningstar ranks 2 of 14 Financial Data & Stock Exchanges companies on the 4-Factor Sector Score, with 68.2 out of 100. 1. [Cboe Global Markets, Inc.](https://www.sectoralpha.in/us/stocks/cboe) CBOE · breaking out · Most evidence points up · 76% evidence 69.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.3/35 · Income 11.7% · Profit 50.3% · 71% evidence Capital efficiency 18.3/25 · ROA 12.4% · ROE 29.4% · GNPA n/a · 68% evidence Valuation 11.2/20 · P/BV 4.51× · P/BV÷ROE 0.15 · 70% evidence Relative strength 14.8/20 · Lead over its industry 5.3% · Lead over S&P 500 14% · 1 year 34.2% · 100% evidence · 7 of 12 weeks ahead Exact sum: 25.3 + 18.3 + 11.2 + 14.8 = 69.6 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. Morningstar, Inc. this page MORN · breaking out · Most evidence points up · 76% evidence 68.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.5/35 · Income 9.3% · Profit 4.2% · 71% evidence Capital efficiency 17.9/25 · ROA 10.3% · ROE 38.2% · GNPA n/a · 68% evidence Valuation 11.5/20 · P/BV 5.79× · P/BV÷ROE 0.15 · 70% evidence Relative strength 19.3/20 · Lead over its industry 9% · Lead over S&P 500 17.4% · 1 year 9.8% · 100% evidence · 12 of 12 weeks ahead Exact sum: 19.5 + 17.9 + 11.5 + 19.3 = 68.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Intercontinental Exchange, Inc.](https://www.sectoralpha.in/us/stocks/ice) ICE · breaking out · Evidence leans up · 76% evidence 62.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.6/35 · Income 9% · Profit 34.5% · 71% evidence Capital efficiency 15.0/25 · ROA 2.7% · ROE 19.6% · GNPA n/a · 68% evidence Valuation 14.6/20 · P/BV 2.35× · P/BV÷ROE 0.12 · 70% evidence Relative strength 10.2/20 · Lead over its industry -3.5% · Lead over S&P 500 4.1% · 1 year 14.7% · 100% evidence · 11 of 12 weeks ahead Exact sum: 22.6 + 15 + 14.6 + 10.2 = 62.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Moody's Corporation](https://www.sectoralpha.in/us/stocks/mco) MCO · turning · Evidence leans up · 80% evidence 58.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.9/35 · Income 9% · Profit 28.5% · 81% evidence Capital efficiency 20.3/25 · ROA 18.4% · ROE 111.5% · GNPA n/a · 68% evidence Valuation 7.9/20 · P/BV 23.05× · P/BV÷ROE 0.21 · 70% evidence Relative strength 4.5/20 · Lead over its industry -6.4% · Lead over S&P 500 1.2% · 1 year 3.2% · 100% evidence · 3 of 12 weeks ahead Exact sum: 25.9 + 20.3 + 7.9 + 4.5 = 58.6 · What this means: Earnings are strong; relative strength in its sector is -6.4% and the one-year return is 3.2%. 5. [TransUnion](https://www.sectoralpha.in/us/stocks/tru) TRU · turning · Evidence leans up · 76% evidence 58.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.4/35 · Income 12.4% · Profit 84.3% · 71% evidence Capital efficiency 16.5/25 · ROA 5.3% · ROE 33.9% · GNPA n/a · 68% evidence Valuation 16.3/20 · P/BV 2.78× · P/BV÷ROE 0.08 · 70% evidence Relative strength 2.2/20 · Lead over its industry -9.3% · Lead over S&P 500 -2.1% · 1 year -2.5% · 100% evidence · 5 of 12 weeks ahead Exact sum: 23.4 + 16.5 + 16.3 + 2.2 = 58.4 · What this means: Earnings are strong; relative strength in its sector is -9.3% and the one-year return is -2.5%. 6. [Nasdaq, Inc.](https://www.sectoralpha.in/us/stocks/ndaq) NDAQ · turning · Evidence leans up · 80% evidence 58.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.7/35 · Income 13.7% · Profit 28.3% · 81% evidence Capital efficiency 15.8/25 · ROA 6.8% · ROE 16.9% · GNPA n/a · 68% evidence Valuation 5.0/20 · P/BV 4.29× · P/BV÷ROE 0.25 · 70% evidence Relative strength 11.7/20 · Lead over its industry 3.1% · Lead over S&P 500 11.4% · 1 year 22.6% · 100% evidence · 8 of 12 weeks ahead Exact sum: 25.7 + 15.8 + 5 + 11.7 = 58.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [MSCI Inc.](https://www.sectoralpha.in/us/stocks/msci) MSCI · turning · Evidence leans up · 64% evidence 55.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.5/35 · Income 12.3% · Profit 13.1% · 71% evidence Capital efficiency 14.5/25 · ROA 21.9% · ROE -51% · GNPA n/a · 68% evidence Valuation 9.8/20 · P/BV -12.98× · P/BV÷ROE n/a · 10% evidence Relative strength 10.1/20 · Lead over its industry -1.8% · Lead over S&P 500 6.2% · 1 year 9.8% · 100% evidence · 3 of 12 weeks ahead Exact sum: 21.5 + 14.5 + 9.8 + 10.1 = 55.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [S&P Global Inc.](https://www.sectoralpha.in/us/stocks/spgi) SPGI · turning · Evidence leans up · 76% evidence 55.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.9/35 · Income 9.7% · Profit 22.6% · 71% evidence Capital efficiency 15.8/25 · ROA 7.6% · ROE 16.6% · GNPA n/a · 68% evidence Valuation 9.6/20 · P/BV 3.29× · P/BV÷ROE 0.2 · 70% evidence Relative strength 7.8/20 · Lead over its industry -8% · Lead over S&P 500 -0.9% · 1 year -6.1% · 100% evidence · 2 of 12 weeks ahead Exact sum: 21.9 + 15.8 + 9.6 + 7.8 = 55.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [FactSet Research Systems Inc.](https://www.sectoralpha.in/us/stocks/fds) FDS · leader · Evidence leans up · 80% evidence 53.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 9.7/35 · Income 6.6% · Profit -10.7% · 81% evidence Capital efficiency 18.1/25 · ROA 11.3% · ROE 24.4% · GNPA n/a · 68% evidence Valuation 6.0/20 · P/BV 5.57× · P/BV÷ROE 0.23 · 70% evidence Relative strength 19.7/20 · Lead over its industry 13.6% · Lead over S&P 500 22.6% · 1 year 26.7% · 100% evidence · 10 of 12 weeks ahead Exact sum: 9.7 + 18.1 + 6 + 19.7 = 53.5 · What this means: Relative strength against the index is 22.6%, and revenue and profit growth are weak. 10. [CME Group Inc.](https://www.sectoralpha.in/us/stocks/cme) CME · breaking out · Evidence leans down · 80% evidence 43.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 15.3/35 · Income 8.9% · Profit 18.5% · 81% evidence Capital efficiency 12.7/25 · ROA 1.4% · ROE 15.7% · GNPA n/a · 68% evidence Valuation 7.0/20 · P/BV 3.55× · P/BV÷ROE 0.23 · 70% evidence Relative strength 8.3/20 · Lead over its industry -4.5% · Lead over S&P 500 3.1% · 1 year 10% · 100% evidence · 8 of 12 weeks ahead Exact sum: 15.3 + 12.7 + 7 + 8.3 = 43.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Value Line, Inc.](https://www.sectoralpha.in/us/stocks/valu) VALU · breaking out · Evidence leans down · 80% evidence 42.9 out of 100 Growth Capital Valuation Relative
12. [MarketWise, Inc.](https://www.sectoralpha.in/us/stocks/mktw) MKTW · turning · Too little evidence to rank firmly · 54% evidence 36.9 out of 100 Growth Capital Valuation Relative
13. [Coinbase Global, Inc.](https://www.sectoralpha.in/us/stocks/coin) COIN · quiet · Most evidence points down · 64% evidence 24.8 out of 100 Growth Capital Valuation Relative
14. [Securitize Corp.](https://www.sectoralpha.in/us/stocks/secz) SECZ · losing its lead · Too little evidence to rank firmly · 47% evidence 33.3 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Financial Data & Stock Exchanges](https://www.sectoralpha.in/us/sectors/financial-data-stock-exchanges), all 14 compared on one page. ## Which companies are close to Morningstar in size? Morningstar is the 11th largest of 14 Financial Data & Stock Exchanges companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Cboe Global Markets, Inc., TransUnion and FactSet Research Systems Inc. Just below it: Securitize Corp., Value Line, Inc. and MarketWise, Inc. ### Financial Data & Stock Exchanges companies close in size

1. [Cboe Global Markets, Inc.](https://www.sectoralpha.in/us/stocks/cboe) $35.9 billion
2. [TransUnion](https://www.sectoralpha.in/us/stocks/tru) $15 billion
3. [FactSet Research Systems Inc.](https://www.sectoralpha.in/us/stocks/fds) $11.7 billion
4. Morningstar, Inc. $8.8 billion
5. [Securitize Corp.](https://www.sectoralpha.in/us/stocks/secz) $1.3 billion
6. [Value Line, Inc.](https://www.sectoralpha.in/us/stocks/valu) $434 million
7. [MarketWise, Inc.](https://www.sectoralpha.in/us/stocks/mktw) $329 million

[All 14 Financial Data & Stock Exchanges companies, largest first](https://www.sectoralpha.in/us/sectors/financial-data-stock-exchanges#all-companies)

### Companies close in size in other industries

1. [SM Energy Company](https://www.sectoralpha.in/us/stocks/sm) $8.9 billion · Oil & Gas Exploration & Production
2. [Oshkosh Corporation](https://www.sectoralpha.in/us/stocks/osk) $8.9 billion · Farm & Heavy Construction Machinery
3. Morningstar, Inc. $8.9 billion
4. [Prosperity Bancshares, Inc.](https://www.sectoralpha.in/us/stocks/pb) $8.8 billion · Banks - Regional
5. [Autoliv, Inc.](https://www.sectoralpha.in/us/stocks/alv) $8.8 billion · Auto Parts

## What else do people ask about Morningstar? ### What were Morningstar's latest quarterly results? Morningstar, Inc. reported total income of $663 M and net profit of $108 M for the Jun 2026 quarter. Income rose 9.6% and profit rose 21.1% compared with a year earlier. Earnings per share were $2.83. The net margin was 16.3%, 1.6 percentage points higher than a year earlier (as of 3 November 2026). ### What is Morningstar's market cap? Morningstar, Inc.'s market capitalisation is $8.8 B at a stock price of $236.71. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Morningstar performing? Morningstar, Inc.'s share price has been stalling near its high for 5 weeks. In its latest quarter, income rose 9.6% and profit rose 21.1% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 15 weeks running (as of 3 November 2026). ### Will Morningstar's stock price go up? This page does not forecast Morningstar, Inc.'s stock price. What it shows instead: the stock price is $236.71, and it has been stalling near its high for 5 weeks. Its P/BV of 8.6× is higher than 66% of its own last 5 years (as of 3 November 2026). ### Where is Morningstar in its business cycle? Morningstar, Inc.'s FY25 net margin was 15.3%, against a 5-year range of 3.8% to 16.3%: the middle of its own range, neither a peak nor a low. The latest quarter was 16.3%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Morningstar story? Biggest thing to watch: the P/BV is higher than 66% of its own history, so the multiple has already done part of the work. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Morningstar a stock worth studying right now? What the numbers show: Morningstar, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.